Head, Division of Hematologic Malignancy Department of Medicine Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

3.4

(47)

New York, NY

Why you should apply for a job to Memorial Sloan Kettering Cancer Center:

  • 77% say women are treated fairly and equally to men
  • 64% say the CEO supports gender diversity
  • Ratings are based on anonymous reviews by Fairygodboss members.
  • Our paid parental leave provides six weeks of fully paid time off to bond with a newborn, newly adopted child, or placed foster child.
  • Full range of best-in-class work/life offerings includes remote/flexible work options; back-up childcare and adult care, childcare centers
  • Income protection provides financial security to help make up for the loss of your regular income should the unexpected occur
  • #Kettering_Cancer_Center_FGB-2023-72574

    Position summary

    e hiring team as your internal resume. Please be sure your profile is fully complete with your skills, relevant experience and education (if required). Click here to learn more. Please note, this link is only accessible for MSK employees.

    Job details

    The Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK) is seeking an exceptional physician investigator and inspirational leader to serve as Head of the Division of Hematologic Malignancies. The Division of Hematologic Malignancies is comprised of over 90 faculty. Direct reports will include Service Chiefs of MSK's Adult Bone Marrow Transplant, Cellular Therapy, Leukemia, Lymphoma, Myeloma and the Benign Hematology Services. These faculty deliver care in New York City as well as across MSK's network that extends from Southern New Jersey to Eastern Long Island. MSK's expertise is increasingly sought by patients beyond our local region, including internationally. Increased work on digital platforms to support this work is expanding.

    The Division of Hematologic Malignancies is dedicated to treating patients with the full spectrum of malignant and premalignant blood disorders. Division faculty perform nearly 600 bone marrow and stem cell transplants each year, and a rapidly growing number of patients are treated with immune effector cells. Division faculty deliver over 85,000 outpatient visits with 6,500 new patients per year. Division faculty include individuals with both wet and dry-lab based research programs dedicated to both fundamental mechanistic discovery, pharmacology, and to clinical translation. Faculty lead a portfolio of over 450 trials that include both investigator-initiated and industry-sponsored studies. Division faculty have led trials that resulted in many FDA approvals of new treatment strategies across the spectrum of blood cancers. They have been highly successful in attracting federal and foundation funding as well as philanthropy to support their efforts.

    The Division Head will have programmatic oversight and responsibility for the Hematologic Malignancy Service Chiefs and their Services. S/he will work with these leaders to shape the scientific, strategic and programmatic priorities for the Division, and will foster clinical, and scientific excellence, talent acquisition and retention, the clinical trial portfolio, grant funding, professional development, mentorship and teaching. S/he will report to the Chair of the Department of Medicine but will work closely with an array of MSK's senior leaders to support the full spectrum of clinical care, training and transdisciplinary research in Hematologic Malignancies. The Division Head will partner with the Chief Scientific Officer, Deputy Physician in Chief for Translational Research, Deputy Physician in Chief for Clinical Research, Sloan Kettering Institute Program Chairs, the Chair of the Human Oncology and Pathogenesis Program (HOPP), and the Pathology Department Chair to nurture a world-class program in Hematologic Malignancies. The Division Head will also work closely with MSK's Hospital President, Chief Nursing and Chief Physician Executives to ensure optimal care and to build programs that meet the current and future needs of patients with or at risk for hematologic malignancies.

    The ideal candidate for this key institutional leadership role is an individual with a vibrant and innovative research program in any field of hematologic malignancies who also has leadership skills and is able to set and share a strategic vision, promote team science and foster a collaborative approach to mentoring trainees and faculty. The ideal candidate is a physician-scientist with expertise in both the delivery of top-quality clinical care and advancing understanding of the biology of these diseases and the development of novel therapeutic strategies for the treatment of hematologic malignancies. Individuals who have the ability to set strategic vision, inspire teams and collaborate well across disciplinary boundaries are most likely to be successful in this key institutional leadership role. The Division Head will serve as a key leader at MSK to chart the future course as the organization embraces many contemporary challenges facing medicine such as integration of artificial intelligence into clinical care and delivering care on a global scale using digital health platforms.

    Interested candidates should apply by sending a brief statement of prior experience, research interests and a CV to Ross Levine, Deputy Physician in Chief for Translational Research, MSK [email protected] and cc Valentina Salkow, Manager, Academic Recruitment, [email protected].

    Expected salary range is $650K-$800K for this role.

    Physician compensation is based on multiple variables. This range represents annual salary only and does not include supplemental performance-based pay or any one-time payments.

    #LI-Onsite

    #LI-Onsite

    Why you should apply for a job to Memorial Sloan Kettering Cancer Center:

  • 77% say women are treated fairly and equally to men
  • 64% say the CEO supports gender diversity
  • Ratings are based on anonymous reviews by Fairygodboss members.
  • Our paid parental leave provides six weeks of fully paid time off to bond with a newborn, newly adopted child, or placed foster child.
  • Full range of best-in-class work/life offerings includes remote/flexible work options; back-up childcare and adult care, childcare centers
  • Income protection provides financial security to help make up for the loss of your regular income should the unexpected occur